ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 90 filers reported holding ENZO BIOCHEM INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $65,000 | -30.1% | 11,790 | +2.3% | 0.00% | – |
| Q4 2017 | $93,000 | -33.1% | 11,521 | -13.6% | 0.00% | – |
| Q3 2017 | $139,000 | -4.1% | 13,331 | +0.4% | 0.00% | – |
| Q2 2017 | $145,000 | +31.8% | 13,279 | -0.2% | 0.00% | – |
| Q1 2017 | $110,000 | +18.3% | 13,311 | +0.1% | 0.00% | – |
| Q4 2016 | $93,000 | +36.8% | 13,303 | +0.3% | 0.00% | – |
| Q3 2016 | $68,000 | -13.9% | 13,265 | +0.1% | 0.00% | – |
| Q2 2016 | $79,000 | +43.6% | 13,257 | +10.4% | 0.00% | – |
| Q1 2016 | $55,000 | +14.6% | 12,007 | +12.5% | 0.00% | – |
| Q4 2015 | $48,000 | +26.3% | 10,674 | -18.7% | 0.00% | – |
| Q1 2015 | $38,000 | -24.0% | 13,128 | +16.0% | 0.00% | – |
| Q4 2014 | $50,000 | -57.3% | 11,318 | -49.2% | 0.00% | – |
| Q2 2014 | $117,000 | +44.4% | 22,259 | +13.9% | 0.00% | – |
| Q1 2014 | $81,000 | +84.1% | 19,540 | +29.4% | 0.00% | – |
| Q4 2013 | $44,000 | +22.2% | 15,099 | +6.3% | 0.00% | – |
| Q3 2013 | $36,000 | +44.0% | 14,203 | +16.6% | 0.00% | – |
| Q2 2013 | $25,000 | – | 12,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |